Lord Abbett & CO. LLC Sells 553,090 Shares of Astera Labs, Inc. $ALAB

Lord Abbett & CO. LLC lessened its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 37.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 943,148 shares of the company’s stock after selling 553,090 shares during the period. Lord Abbett & CO. LLC’s holdings in Astera Labs were worth $156,902,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Eurizon Capital SGR S.p.A. bought a new stake in Astera Labs in the 4th quarter worth approximately $18,708,000. Nordea Investment Management AB bought a new stake in Astera Labs in the 4th quarter worth approximately $2,028,000. Geneva Partners LLC bought a new stake in Astera Labs in the 3rd quarter worth approximately $1,876,000. Numerai GP LLC lifted its position in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after buying an additional 7,992 shares during the last quarter. Finally, Swedbank AB lifted its position in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $367.15 on Friday. The business’s 50 day simple moving average is $237.17 and its two-hundred day simple moving average is $178.94. The stock has a market capitalization of $62.93 billion, a P/E ratio of 248.07, a price-to-earnings-growth ratio of 4.87 and a beta of 3.95. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $390.99.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,321,256 shares of company stock valued at $480,893,146 in the last ninety days. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ALAB. Needham & Company LLC boosted their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Royal Bank Of Canada boosted their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Morgan Stanley boosted their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Jefferies Financial Group restated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.